首页 | 官方网站   微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   201篇
  免费   1篇
  国内免费   1篇
医药卫生   203篇
  2021年   5篇
  2015年   2篇
  2014年   3篇
  2013年   2篇
  2012年   2篇
  2006年   3篇
  1998年   4篇
  1997年   7篇
  1996年   7篇
  1995年   3篇
  1994年   5篇
  1993年   7篇
  1990年   3篇
  1989年   8篇
  1988年   4篇
  1987年   3篇
  1986年   3篇
  1984年   3篇
  1983年   4篇
  1982年   3篇
  1981年   5篇
  1980年   7篇
  1979年   2篇
  1978年   4篇
  1977年   5篇
  1976年   5篇
  1974年   3篇
  1968年   6篇
  1967年   2篇
  1966年   2篇
  1961年   2篇
  1959年   8篇
  1958年   10篇
  1957年   3篇
  1956年   6篇
  1955年   9篇
  1954年   6篇
  1949年   6篇
  1948年   1篇
  1946年   1篇
  1943年   1篇
  1935年   2篇
  1933年   1篇
  1931年   1篇
  1930年   1篇
  1928年   3篇
  1925年   1篇
  1924年   1篇
  1921年   1篇
  1902年   2篇
排序方式: 共有203条查询结果,搜索用时 15 毫秒
1.
In order to evaluate the effects of pentoxifylline on sperm motility and longevity, a controlled in-vitro study was conducted on normozoospermic donor semen samples using the Cellsoft automated system for sperm motility analysis. After incubation and selection, pentoxifylline was found to improve the recovery of spermatozoa and to increase their velocity. In the subgroup of progressively motile spermatozoa, curvilinear velocity was also enhanced. It is concluded that pentoxifylline has an effect on the vigour, but not on the pattern, of sperm motion. Pentoxifylline did not improve the motility characteristics of senescent spermatozoa in normozoospermic sperm samples. Sperm survival, as shown by supra-vital staining, and motility longevity both decreased with time after pentoxifylline treatment.  相似文献   
2.
3.
4.
5.

Introduction

The treatment of portal hypertension is complex and the the best strategy depends on the underlying disease (cirrhosis vs. schistosomiasis), patient''s clinical condition and time on it is performed (during an acute episode of variceal bleeding or electively, as pre-primary, primary or secondary prophylaxis). With the advent of new pharmacological options and technical development of endoscopy and interventional radiology treatment of portal hypertension has changed in recent decades.

Aim

To review the strategies employed in elective and emergency treatment of variceal bleeding in cirrhotic and schistosomotic patients.

Methods

Survey of publications in PubMed, Embase, Lilacs, SciELO and Cochrane databases through June 2013, using the headings: portal hypertension, esophageal and gastric varices, variceal bleeding, liver cirrhosis, schistosomiasis mansoni, surgical treatment, pharmacological treatment, secondary prophylaxis, primary prophylaxis, pre-primary prophylaxis.

Conclusion

Pre-primary prophylaxis doesn''t have specific treatment strategies; the best recommendation is treatment of the underlying disease. Primary prophylaxis should be performed in cirrhotic patients with beta-blockers or endoscopic variceal ligation. There is controversy regarding the effectiveness of primary prophylaxis in patients with schistosomiasis; when indicated, it is done with beta-blockers or endoscopic therapy in high-risk varices. Treatment of acute variceal bleeding is systematized in the literature, combination of vasoconstrictor drugs and endoscopic therapy, provided significant decline in mortality over the last decades. TIPS and surgical treatment are options as rescue therapy. Secondary prophylaxis plays a fundamental role in the reduction of recurrent bleeding, the best option in cirrhotic patients is the combination of pharmacological therapy with beta-blockers and endoscopic band ligation. TIPS or surgical treatment, are options for controlling rebleeding on failure of secondary prophylaxis. Despite the increasing evidence of the effectiveness of pharmacological and endoscopic treatment in schistosomotic patients, surgical therapy still plays an important role in secondary prophylaxis.  相似文献   
6.
7.
8.
Presurgical infant orthopaedics (PIO) is widely used to treat children with clefts. However, consensus on the relevance of this treatment is lacking. A prospective clinical trial is under way to investigate the effects of PIO in unilateral cleft lip and palate (UCLP) babies. The prelexical development of two groups of UCLP babies was compared at 12 and 18 months of age; one group received PIO, while the other did not. Analysis of prelexical utterances was performed by means of a perceptually based sensori-motoric classification system. Consonant-like elements were also assessed by means of phonetic analysis of place and manner of articulation. At the age of 12 months the PIO babies showed enhanced use of alveolar articulations. However, the effect of PIO seemed to be transient, because the recordings obtained at 18 months showed similar use of all variables of sound production in the two groups. The longitudinal character of the clinical trial will enable the evaluation of the long-term effects of PIO as the children grow older.  相似文献   
9.
Explants of a well-differentiated fourth ventricle ependymoma were grown on collagen-coated coverslips and in organ culture systems using gelatin sponge foam matrices and Millipore filter platforms. Viable explants were maintained on Millipore filter platforms up to 44 days and on sponge foam matrices up to 86 days. The structure of ependymal rosettes was well maintained throughout the period of study. By electron microscopy, additional features of differentiation were seen after 3 weeks, consisting of an increase in size and complexity of microrosettes, to which large numbers of cellular apical profiles contributed. Cilia with variable internal configurations were present. After 4 weeks there was frequent ependymal differentiation along the surface of the explants at their interface with the supporting matrix. Increased gliofibrillogenesis and glycogen rosettes were also evident after 3 weeks in culture. The explants were intensely positive when tested by immunofluorescence for the antigen of the glial fibrillary acidic protein. After 3 weeks in vitro , dense bands of basement membrane material forming complex intercellular finger-like projections became prominent.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号